NCCPF No:- 102082
Catalogue Information : |
|||||
Candida | glabrata | ||||
102082 | |||||
Senders Details : |
|||||
pgimer | NA | ||||
NA | |||||
05-Feb-2020 | Pus | ||||
P-3321 | |||||
MALDI Based Identification : |
|||||
candida glabrata | 99.9 Biomereux | ||||
02-May-2022 | |||||
VITEK Based Identification : |
|||||
DNA Sequencing Based Identification : |
|||||
Candida glabrata | ITS | ||||
100% | 27-Sep-2022 | ||||
1665402372_102082_1.pdf | 102082 | ||||
102082 | |||||
ANTIFUNGAL SUSCEPTIBILITY TESTING (AFST) CLSI METHOD : |
|||||
Yeast | Candida | ||||
candida glabrata | |||||
1 | Amphotericin B | 1.000 | Sensitive | ||
2 | Fluconazole | 16.000 | Sensitive | ||
3 | Voriconazole | 2.000 | Resistant | ||
4 | Itraconazole | 4.000 | Sensitive | ||
5 | Caspofungin | 1.000 | Resistant | ||
6 | Micafungin | 0.060 | Sensitive | ||
7 | posaconazole | 4.000 | Resistant | ||
8 | Anindulifungin | 0.030 | Sensitive |